Search - tctmd.com

Displaying 461 - 480 of 542

Sort: Relevancy | Date

News Daily News

Popular CV Risk Calculator Is Not Accurate Among Patients at Low Socioeconomic Standing

Yael L. Maxwell

August 31, 2017

News Conference News ESC 2017

IMPACT-AF: Education, Feedback Boost Oral Anticoagulation Use for A-fib

Todd Neale

August 30, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

News Daily News

Women With A-fib Less Likely to Get Oral Anticoagulants Regardless of Risk

Leah Lawrence

August 03, 2017

News Daily News

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Michael O'Riordan

August 02, 2017

News Daily News

‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low

Michael O'Riordan

August 01, 2017

News Daily News

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Leah Lawrence

July 24, 2017

News Daily News

Pregnancy-Associated SCAD Is a Particularly High-Risk Subset of the Condition

Todd Neale

July 17, 2017

News Features

Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana

Ashley Lyles

July 13, 2017

News Conference News SCCT 2017

Coronary Calcium Scores in 2017: Useful, Yes, but Hard Outcomes Data Still Lacking

Yael L. Maxwell

July 13, 2017

News Daily News

Black Men Have Twofold Higher Risk of Dying From First CHD Event

Michael O'Riordan

July 10, 2017

News Daily News

Anticoagulation in Pregnant Women With Mechanical Heart Valves: A Balancing Act

Caitlin E. Cox

May 31, 2017

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

News Daily News

Registry Study Supports Curbing Cholesterol Screening for Young Adults Because of Low Overall Risk

Yael L. Maxwell

May 15, 2017

News Daily News

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Michael O'Riordan

May 12, 2017

News Daily News

Who Should Get a Statin? Guidelines Don’t Match Up

Michael O'Riordan

April 20, 2017

News Daily News

One in Five Acute MI Patients Drop Statins Within 2 Years

Michael O'Riordan

April 20, 2017

News Daily News

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

Michael O'Riordan

April 04, 2017

News Daily News

Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows

Michael O'Riordan

March 31, 2017

News Conference News ACC 2017

High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI

Michael O'Riordan

March 21, 2017

Advertisement

Popular CV Risk Calculator Is Not Accurate Among Patients at Low Socioeconomic Standing

IMPACT-AF: Education, Feedback Boost Oral Anticoagulation Use for A-fib

Evolocumab Not Cost-Effective at Current List Price

Women With A-fib Less Likely to Get Oral Anticoagulants Regardless of Risk

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Pregnancy-Associated SCAD Is a Particularly High-Risk Subset of the Condition

Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana

Coronary Calcium Scores in 2017: Useful, Yes, but Hard Outcomes Data Still Lacking

Black Men Have Twofold Higher Risk of Dying From First CHD Event

Anticoagulation in Pregnant Women With Mechanical Heart Valves: A Balancing Act

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Registry Study Supports Curbing Cholesterol Screening for Young Adults Because of Low Overall Risk

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Who Should Get a Statin? Guidelines Don’t Match Up

One in Five Acute MI Patients Drop Statins Within 2 Years

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows

High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content